MGAM
McGowan Group Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,553
| Closed | -$248K | – | 134 |
|
|
2024
Q3 | $248K | Buy |
8,553
+19
| +0.2% | +$550 | 0.03% | 111 |
|
|
2024
Q2 | $239K | Buy |
+8,534
| New | +$239K | 0.03% | 112 |
|
|
2023
Q3 | – | Sell |
-6,929
| Closed | -$254K | – | 136 |
|
|
2023
Q2 | $254K | Sell |
6,929
-320
| -4% | -$11.7K | 0.04% | 123 |
|
|
2023
Q1 | $296K | Buy |
7,249
+53
| +0.7% | +$2.16K | 0.05% | 110 |
|
|
2022
Q4 | $369K | Buy |
7,196
+618
| +9% | +$31.7K | 0.06% | 93 |
|
|
2022
Q3 | $288K | Buy |
6,578
+37
| +0.6% | +$1.62K | 0.05% | 91 |
|
|
2022
Q2 | $343K | Buy |
6,541
+60
| +0.9% | +$3.15K | 0.06% | 84 |
|
|
2022
Q1 | $336K | Buy |
+6,481
| New | +$336K | 0.05% | 91 |
|
|
2020
Q3 | – | Sell |
-17,862
| Closed | -$584K | – | 92 |
|
|
2020
Q2 | $584K | Buy |
17,862
+3,675
| +26% | +$120K | 0.11% | 54 |
|
|
2020
Q1 | $463K | Buy |
14,187
+9,038
| +176% | +$295K | 0.1% | 54 |
|
|
2019
Q4 | $202K | Buy |
+5,149
| New | +$202K | 0.03% | 90 |
|
|
2019
Q3 | – | Sell |
-5,271
| Closed | -$228K | – | 97 |
|
|
2019
Q2 | $228K | Sell |
5,271
-45
| -0.8% | -$1.95K | 0.04% | 98 |
|
|
2019
Q1 | $226K | Sell |
5,316
-8
| -0.2% | -$340 | 0.04% | 98 |
|
|
2018
Q4 | $232K | Buy |
5,324
+533
| +11% | +$23.2K | 0.04% | 86 |
|
|
2018
Q3 | $211K | Buy |
+4,791
| New | +$211K | 0.04% | 103 |
|